Department of Biochemistry, University of Iowa College of Medicine, Iowa City, IA 52242-1109, United States.
Department of Biochemistry, University of Iowa College of Medicine, Iowa City, IA 52242-1109, United States.
DNA Repair (Amst). 2018 Nov;71:127-134. doi: 10.1016/j.dnarep.2018.08.016. Epub 2018 Aug 24.
Normal DNA replication is blocked by DNA damage in the template strand. Translesion synthesis is a major pathway for overcoming these replication blocks. In this process, multiple non-classical DNA polymerases are thought to form a complex at the stalled replication fork that we refer to as the mutasome. This hypothetical multi-protein complex is structurally organized by the replication accessory factor PCNA and the non-classical polymerase Rev1. One of the non-classical polymerases within this complex then catalyzes replication through the damage. Each non-classical polymerase has one or more cognate lesions, which the enzyme bypasses with high accuracy and efficiency. Thus, the accuracy and efficiency of translesion synthesis depends on which non-classical polymerase is chosen to bypass the damage. In this review article, we discuss how the most appropriate polymerase is chosen. In so doing, we examine the structural motifs that mediate the protein interactions in the mutasome; the multiple architectures that the mutasome can adopt, such as PCNA tool belts and Rev1 bridges; the intrinsically disordered regions that tether the polymerases to PCNA and to one another; and the kinetic selection model in which the most appropriate polymerase is chosen via a competition among the multiple polymerases within the mutasome.
正常的 DNA 复制会被模板链上的 DNA 损伤所阻断。跨损伤合成是克服这些复制障碍的主要途径。在这个过程中,多个非经典 DNA 聚合酶被认为在停滞的复制叉处形成一个复合物,我们称之为突变体。这个假设的多蛋白复合物由复制辅助因子 PCNA 和非经典聚合酶 Rev1 结构组织。该复合物中的一个非经典聚合酶随后催化通过损伤的复制。每个非经典聚合酶都有一个或多个对应的损伤,该酶可以高度准确和有效地绕过这些损伤。因此,跨损伤合成的准确性和效率取决于选择哪种非经典聚合酶来绕过损伤。在这篇综述文章中,我们讨论了如何选择最合适的聚合酶。在这样做的过程中,我们研究了介导突变体中蛋白质相互作用的结构基序;突变体可以采用的多种结构,如 PCNA 工具带和 Rev1 桥;将聚合酶与 PCNA 和彼此连接的固有无序区域;以及通过突变体中多个聚合酶之间的竞争选择最合适聚合酶的动力学选择模型。